2021 Second Quarter Earnings (Unaudited) July 27, 2021 Photo reference: The sample name is “Polymeric Netting with Ribbons.” The samples have use in absorbent articles for Health Care and Consumer products. -- 1 of 16 -- 22 2021 Q2 Earnings – July 27, 2021. All rights reserved. Events 2021 Earnings Calls Q3 October 26 -- 2 of 16 -- 33 2021 Q2 Earnings – July 27, 2021. All rights reserved. Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8- K. The information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments. This presentation refers to certain non-GAAP financial measures. Refer to 3M’s July 27, 2021, press release for descriptions of non-GAAP financial measures such free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non- GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release. Note on non-GAAP financial measures -- 3 of 16 -- 44 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 … continued strong growth and execution Vision • Broad-based organic growth across all business groups and geographic areas • Strong growth and operating rigor driving increased earnings, margins and robust cash flow • Global economic recovery continues to improve, though uncertainty remains from COVID-19 • Ongoing strength in end markets including home improvement, oral care and industrial; health care elective procedure volumes increasing • Supply chain, raw material and logistics headwinds expected to persist through 2021; declining pandemic- related demand for disposable respirators • Prioritizing investments in growth, productivity and sustainability • Updating full-year 2021 guidance -- 4 of 16 -- 55 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 summary 21.4% year-on-year Organic local- currency growth 22.0% +2.4 ppts year-on-year Adjusted operating margin $2.59 +44% year-on-year Adjusted earnings per share Sales of $8.9B, up 24.7% year-on-year Organic sales growth across all business groups led by Transportation & Electronics and Health Care Accelerating investments in growth platforms including automotive electrification, air quality, home improvement, and biopharma filtration Health care respirator demand slowing, shifting output to industrial and consumer end markets; adjusting manufacturing production volumes Strong operational execution despite significant year-on-year increase in raw materials and logistics costs Delivering strong cash flow and continuing to strengthen capital structure and financial flexibility -- 5 of 16 -- 66 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 adjusted operating margin and EPS +9.0% Adjusted Operating Income Margin Adjusted Earnings Per Share Q2 2020 19.6% $1.81 Organic volume/productivity and other +4.1% +$0.89 Strong organic volume growth and productivity; benefits from restructuring actions; application of Brazilian Supreme Court social tax ruling (+1.0%; +$0.12); increases in certain legal reserves and ongoing legal costs Price/raw material -1.4% -$0.17 Selling price increases more than offset by higher raw materials and logistics costs Divestitures* -0.1% -$0.02 Drug delivery divestiture (May 2020) FX -0.2% +$0.08 Net of hedge impact; full-year 2021 FX benefit of approximately $0.15 per share, remains unchanged Other expense/income NA +$0.06 Primarily non-operating pension benefit (+$0.05) Tax rate** NA -$0.03 Adjusted Q2 2021 tax rate 21.5% versus 20.7% in prior year; full-year 2021 tax rate range of 20% to 21%, remains unchanged Shares outstanding NA -$0.03 Average diluted shares up 1% Q2 2021 22.0% $2.59 * Includes impact of lost income from divested businesses. ** The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. -- 6 of 16 -- 77 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 cash flow and balance sheet Proactive balance sheet management • Net debt of $12.7B, down $3.5B, or 22% year-on-year Adjusted free cash flow conversion • Q2: 103%, down 44 ppts; YTD: 94%, down 13 ppts • Q2 and YTD year-on-year decline in conversion of 37 and 17 ppts, respectively, due to timing of prior year income tax payment Capital expenditures • Q2: $394M; YTD $704M • FY 2021: $1.8B to $2.0B Cash returned to shareholders • Dividends: Q2 $858M; YTD $1.7B • Gross share repurchases: Q2 $503M; YTD $734M $1.6B +2% year-on-year Adjusted free cash flow 103% -44 ppts year-on-year Adjusted free cash flow conversion $1.4B +61% year-on-year Cash returned to shareholders -- 7 of 16 -- 88 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 Business Group performance Organic Growth Segment Operating Margin Commentary Safety & Industrial +17.6% 22.1% • Continued end-market strength (industrial, automotive, electronics, construction) driving growth in autobody repair, roofing granules, abrasives, industrial adhesives and tapes, and electrical OEM/MRO • Disposable respirator sales up 3% organically year-on-year; however, declined 11% sequentially • Operating margins -1.3 ppts year-on-year; increases in raw materials, logistics and legal costs partially offset by sales growth Transportation & Electronics +24.2% 22.0% • Organic growth led by automotive OEM; continued strength in semiconductor, factory automation and consumer electronics (TVs/tablets) • Operating margins +3.4 ppts year-on-year; improvement due to sales growth, partially offset by rising raw materials and logistics costs Health Care +23.2% 25.3% • Organic growth led by oral care due to higher patient visits; continued improvement in medical solutions due to rising elective procedure volumes; food safety benefited as food services activity returned • Operating margins +8.8 ppts year-on-year; improvement due to sales growth, partially offset by rising raw materials and logistics costs Consumer +17.8% 21.0% • Continued strength in home improvement and home cleaning; improving office and stationery demand driven by return-to-school and workplace trends • Operating margins -1.6 ppts year-on-year; increases in raw materials, logistics, outsourced hardgoods manufacturing costs, and investments in advertising/merchandising, partially offset by sales growth -- 8 of 16 -- 99 2021 Q2 Earnings – July 27, 2021. All rights reserved. Updating 2021 planning estimates Second-half 2021 expectations Third quarter items of note • Global macroeconomic and end-market recovery continues, but remain fluid and uneven • Improving health care elective procedure volumes; and return-to-workplace/school trends • Decline in pandemic-related disposable respirator demand of $100-300M year-on-year • Continued semiconductor chip supply constraints negatively impacting electronics & auto OEM production volumes • Raw materials and logistics inflation persists; now expect full- year 2021 headwind of $0.65-$0.80 per share vs. $0.30- $0.50, prior; $0.40-$0.55 per share in the second half • Restructuring program on track, anticipate pre-tax restructuring charge of $60-110M • Maintaining strong execution and operating rigor while continuing to invest in growth, productivity and sustainability • End-market trends: • Health care elective procedure volumes to increase • Home improvement remains strong • Return-to-school and workplace trends improving • Smartphone shipments down HSD year-on-year • Global car & light truck builds down 3% year-on-year • Decline in pandemic-related disposable respirator demand of $50-100M year-on-year ($100-150M sequentially) • Expect year-on-year operating margin headwind of 50-100 bps from raw materials/logistics costs net of selling price • Pre-tax restructuring charge of $50-75M • Increase in legal defense costs year-on-year • Higher investments in growth, productivity and sustainability Organic local-currency growth 6% to 9% vs. 3% to 6%, prior Earnings per share $9.70 to $10.10 vs. $9.20 to $9.70, prior Free cash flow conversion 90% to 100% vs. 95% to 105%, prior -- 9 of 16 -- 10 10 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q&A Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President & Chief Financial Officer Bruce Jermeland Senior Vice President, Investor Relations -- 10 of 16 -- 11 11 2021 Q2 Earnings – July 27, 2021. All rights reserved. Appendix -- 11 of 16 -- 12 12 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 P&L ($M) Q2 2020 Q2 2021 Change Sales $7,176 $8,950 +24.7% Gross profit $3,371 $4,231 +25.5% % to sales 47.0% 47.3% +0.3 pts SG&A $1,594 $1,746 +9.6% % to sales 22.2% 19.6% -2.6 pts R&D & related $424 $514 +21.0% % to sales 5.9% 5.7% -0.2 pts Gain on sale of businesses ($387) ---- NM % to sales (5.4%) ---- NM Operating income $1,740 $1,971 +13.2% % to sales 24.3% 22.0% -2.3 pts Net income $1,306 $1,524 +16.7% GAAP earnings per share $2.25 $2.59 +15.1% -- 12 of 16 -- 13 13 2021 Q2 Earnings – July 27, 2021. All rights reserved. Q2 2021 sales recap Americas EMEA APAC Worldwide Organic volume +25.3% +19.8% +15.9% +21.3% Price +0.3% +0.3% -0.5% +0.1% Organic local-currency +25.6% +20.1% +15.4% +21.4% Acquisitions/Divestitures -0.7% -1.6% ---- -0.7% FX +1.2% +10.2% +4.8% +4.0% Total growth +26.1% +28.7% +20.2% +24.7% U.S. Canada Mexico Brazil China/HK Japan Organic local-currency +21.9% +36.6% +59.8% +54.4% +12.3% +12.2% -- 13 of 16 -- 14 14 2021 Q2 Earnings – July 27, 2021. All rights reserved. Business segment information ($M) Net Sales Q2 2021 Sales Growth Organic local-currency by Geographic Area Business Segment Operating Income/Adjusted Operating Income* Business Segment Operating Margin/Adjusted Operating Margin* Business groups Q2 2020 Q2 2021 Organic local- currency FX M&A Total Sales Change Americas Asia Pacific EMEA Q2 2020 Q2 2021 Percent change Q2 2020 Q2 2021 Safety & Industrial $2,657 $3,254 17.6% 4.8% 0.0% 22.4% 21% 18% 10% $623 $718 15.3% 23.4% 22.1% Transportation & Electronics $1,937 $2,482 24.2% 3.9% 0.0% 28.1% 34% 17% 39% $360 $546 51.6% 18.6% 22.0% Health Care $1,823 $2,278 23.2% 4.3% -2.6% 24.9% 25% 14% 26% $301 $576 91.9% 16.5% 25.3% Consumer $1,231 $1,482 17.8% 2.6% 0.0% 20.4% 20% 9% 19% $278 $311 11.8% 22.6% 21.0% Elimination of Dual Credit ($473) ($547) ($119) ($138) Total Operating Business Segment $1,443 $2,013 Corporate & Unallocated $1 $1 ($35) ($42) Total $7,176 $8,950 21.4% 4.0% -0.7% 24.7% 25.6% 15.4% 20.1% $1,408 $1,971 39.9% 19.6% 22.0% * “Corporate and Unallocated” and “Total” provided on an adjusted basis Organic local-currency = organic volume + price -- 14 of 16 -- 15 15 2021 Q2 Earnings – July 27, 2021. All rights reserved. Additional sales detail ($M) Net Sales Business groups Q2 2020 Q2 2021 Abrasives 242 353 Automotive Aftermarket 202 313 Closure and Masking Systems 235 254 Electrical Materials 251 319 Industrial Adhesives & Tapes 545 761 Personal Safety 1,095 1,133 Roofing Granules 86 121 Other Safety & Industrial 1 0 Total Safety & Industrial Business Group 2,657 3,254 Advanced Materials 236 304 Automotive & Aerospace 268 469 Commercial Solutions 327 454 Electronics 884 998 Transportation Safety 222 259 Other Transportation & Electronics 0 (2) Total Transportation & Electronics Business Group 1,937 2,482 ($M) Net Sales Business groups Q2 2020 Q2 2021 Drug Delivery 41 0 Food Safety 78 95 Health Information Systems 276 299 Medical Solutions 1,067 1,275 Oral Care 144 364 Separation & Purification Sciences 216 248 Other Health Care 1 (3) Total Health Care Business Group 1,823 2,278 Consumer Health & Safety 120 163 Home Care 257 272 Home Improvement 564 666 Stationery & Office 257 352 Other Consumer 33 29 Total Consumer Business Group 1,231 1,482 Corporate & Unallocated 1 1 Elimination of Dual Credit (473) (547) Total 7,176 8,950 -- 15 of 16 -- -- 16 of 16 --